Literature DB >> 19922830

[(18)F-FDG PET-CT and respiratory synchronization: effect in the detection and catalogation of pulmonary lesions].

A M García Vicente1, A Soriano Castrejón, P Talavera Rubio, V M Poblete García, A Palomar Muñoz, I Cepedello Boiso, B González García, J M Cordero García, M Bellón Guardia, J P Pilkington Woll.   

Abstract

UNLABELLED: The respiratory movement reduces the sensitivity in the detection of pulmonary lesions. The synchronized acquisition of PET with respiratory movement (4D) can reduce this inconvenient. Our objective was assess the effect of 4D PET-CT in the metabolic activity of (18)F FDG and final classification of pulmonary lesions.
MATERIAL AND METHODS: 12 patients with 18 pulmonary lesions with sizes within 0.8-4cm were assessed. The maximum SUV was obtained in the imaging acquired in standard conditions (3D) and the obtained in the respiratory period with higher metabolic activity in 4D images. The difference of percentage between both values was calculated. Moreover were evaluated the changes of the classification of pulmonary nodes (benign or malignant) obtained from the assessment of 4D and 3D PET images.
RESULTS: 17/18 pulmonary lesions showed an increase in the SUV(max) value in the 4D with respect to 3D image. 5 lesions showed SUV(max) values >2.5 in 4D image and <2.5 in 3D image. From these 3 were correctly catalogued as malignant with 4D although the number of false positive increased to 2.
CONCLUSION: (18)F-FDG 4D PET-CT shows values of metabolic activity more realistic allowing the correct classification reducing the false negative although increasing the false positive.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19922830     DOI: 10.1016/S0212-6982(09)00009-3

Source DB:  PubMed          Journal:  Rev Esp Med Nucl        ISSN: 0212-6982


  1 in total

1.  (18)F-FDG-PET/CT in the assessment of pulmonary solitary nodules: comparison of different analysis methods and risk variables in the prediction of malignancy.

Authors:  Ober van Gómez López; Ana María García Vicente; Antonio Francisco Honguero Martínez; Germán Andrés Jiménez Londoño; Carlos Hugo Vega Caicedo; Pablo León Atance; Ángel María Soriano Castrejón
Journal:  Transl Lung Cancer Res       Date:  2015-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.